S
STARPHARMA HOLDINGS LTD
ASX: SPL (STARPHARMA FPO [SPL])
Kemas kini terakhir: 6 jam lalu0.800
0.03 (3.90%)
| Penutupan Terdahulu | 0.770 |
| Jumlah Dagangan | 3,537,042 |
| Harga / Jualan (P/S) | 28.60 |
| Harga / Buku (P/B) | 27.70 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -222.17% |
| EPS Cair (TTM) | -0.030 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -69.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 10.68% |
| Nisbah Semasa (MRQ) | 5.41 |
| Aliran Tunai Operasi (OCF TTM) | -11.07 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -6.33 M |
| Pulangan Atas Aset (ROA TTM) | -21.28% |
| Pulangan Atas Ekuiti (ROE TTM) | -43.47% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (AU) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | STARPHARMA FPO [SPL] | - | - |
AISkor Stockmoo
0.3
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | 4.0 |
| Purata | 0.33 |
|
Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 20.27% |
| % Dimiliki oleh Institusi | 23.61% |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |